| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $68.0M | -17.6% |
| R&D Expense | $677.0M | -2.9% |
| SG&A Expense | $129.0M | +11.3% |
| Operating Income | -$1.85B | -153.5% |
| Pre-tax Income | -$1.72B | -126.7% |
| Income Tax | $0 | +100.0% |
| Net Income | -$1.72B | -128.1% |
| EPS (Basic) | -$1.51 | -23.8% |
| EPS (Diluted) | -$1.51 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $262.0M | -83.7% |
| Short-term Investments | $839.0M | — |
| Current Assets | $1.12B | -33.4% |
| Total Assets | $2.00B | -45.8% |
| Current Liabilities | $83.0M | -8.5% |
| Total Liabilities | $217.0M | -37.7% |
| Stockholders' Equity | $1.78B | -46.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$508.0M | +9.8% |
| Capital Expenditures | $15.0M | -68.8% |
| Investing Cash Flow | -$852.0M | -441.0% |
| Financing Cash Flow | $11.0M | -99.3% |
| Free Cash Flow | -$523.0M | +14.5% |
| -23.8% |